Silo Pharma, Inc. — Form 8-K
Filed October 2, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 72/100
What the filing says
On October 1, 2026, Silo Pharma acquired software assets (Klone brand web-based tools, source code, object code, and related intellectual property) from Norsight Consulting Inc. The consideration was 300,000 common stock purchase warrants with a $1.51 exercise price, 5-year term (exercisable April 1, 2027 through September 30, 2031), and cashless exercise option. Warrants carry a 4.99% beneficial ownership cap (or 9.99% at Norsight's election) and are subject to a 12-month lockup on any resulting shares. Norsight represents exclusive IP ownership, no third-party infringement, and absence of problematic open-source licensing (except identified exceptions on Exhibit B).
Why this rating
Material acquisition expanding product portfolio for micro-cap ($5.3M). 300k warrants at $1.51 ~$453k notional value (8.5% of market cap). Strategic IP asset adds revenue-generating Klone software to pipeline. Counterparty Norsight is minor constraint via lockup and representations, not major risk. Positive but execution-dependent.
Tradability signal
NO TRADE
No trade: only ~$0k traded in the last 30 min — too illiquid to enter and exit. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
before filing · preread $1.50 ▲ 2.88% | at our read · unknown $1.46 | +10 min · unknown $1.30 ▼ 10.84% | +30 min · unknown $1.39 ▼ 4.66% | +1 hr · unknown $1.39 ▼ 5.01% | +4 hrs · unknown $1.47 ▲ 0.69% |
The stock had already moved -2.80% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.